title: Zometa European Study (ZEUS): another failed crusade for the holy grail of prostate cancer bone metastases prevention?
authors.affiliation: Service d'Urologie, Insitut de Recherche clinique (IREC), Cliniques universitaires Saint Luc, Av. Hippocrates, 10, B-1200 Bruxelles, Belgium. Electronic address: Bertrand.tombal@uclouvain.be.
authors.forename: Bertrand
authors.initials: B
authors.lastname: Tombal
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000517:prevention & control*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles